IRIX — IRIDEX Corporation

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.71 Analyst target: $2.75 Upside: 286.29%

About IRIDEX Corporation

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat vision-threatening eye diseases in ophthalmology. The company is headquartered in Mountain View, California.

See the full interactive analysis & chart →

Informational only — not investment advice.